financial guidance
T2 Biosystems Lays off 30 Percent of Workforce as Q1 Revenues Drop 71 Percent
The company also announced that it has submitted its T2Biothreat Panel to the US Food and Drug Administration for 510(k) clearance.
SomaLogic Q1 Revenues Fall 11 Percent but Beat Wall Street Consensus
Six weeks after a management shakeup, the proteomics firm is looking for unspecified "inorganic" opportunities to become profitable.
Cue Health Q1 Revenues Drop 86 Percent
The firm reported a net loss of $94.2 million, or $.62 per share, compared to net income of $2.8 million, or $.02 per share, in Q1 2022.
GeneDx Q1 Revenues Fall 20 Percent but Beat Consensus Estimate
Molecular diagnostic testing volume grew across all continuing operations in Q1 as GeneDx completed the shutdown of underperforming Sema4 assets.
Exact Sciences Reports 24 Percent Spike in Q1 Revenues, Ups Full-Year Revenue Guidance
Exact reported revenues of $602.5 million compared to $486.6 million a year ago, surpassing analysts' average estimate of $543.5 million.
May 4, 2023
QuidelOrtho Q1 Revenues Drop 16 Percent
Apr 25, 2023
Apr 25, 2023
Labcorp Q1 Revenues Down 3 Percent
Mar 27, 2023
DiaSorin 2022 Revenues Grow 10 Percent
Feb 23, 2023
Feb 16, 2023